DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Uchida Y, Kouyama JI, Naiki K. , et al.
Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.
Hepatol Res 2016;
46 (12) 1234-1246
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.